| HGNC Family | Solute carriers (SLC) |
| Name | solute carrier family 34 (type II sodium/phosphate cotransporter), member 2 |
| Description | The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is increased at lower pH. Defects in this gene are a cause of pulmonary alveolar microlithiasis. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2010] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC34A2 encodes the type IIb sodium–phosphate cotransporter (NaPi‐IIb), a key mediator of phosphate homeostasis in several organs—most notably in the lung. Loss‐of‐function mutations in SLC34A2 impair phosphate clearance in alveolar type II cells, resulting in the pathological deposition of calcium phosphate microliths observed in pulmonary alveolar microlithiasis (PAM). Genetic analyses in both familial and sporadic cases of PAM have uncovered a spectrum of mutations (including frameshifts, nonsense mutations, and promoter deletions) that abrogate normal protein function, thereby underlining the indispensable role of SLC34A2 in maintaining alveolar phosphate balance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its fundamental role in phosphate transport, aberrant expression of SLC34A2 has been implicated in the pathogenesis of diverse malignancies. In non–small cell lung cancer, for example, microRNA‐mediated suppression of SLC34A2 leads to activation of the Wnt/β–catenin cascade and enhanced tumor cell growth and invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": " In breast cancer, upregulation of SLC34A2 in cancer stem cell subpopulations not only potentiates chemoresistance via a SLC34A2–Bmi1–ABCC5 axis but also sustains stemness through PI3K/AKT/SOX2 signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "17"}]}, {"type": "t", "text": " Similarly, elevated SLC34A2 expression has been reported in thyroid cancers"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": ", as well as in ovarian malignancies where it appears associated with tumor development and metastasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "20", "end_ref": "23"}]}, {"type": "t", "text": " In colorectal cancer, deregulated SLC34A2 promotes cell proliferation and chemoresistance"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "26"}]}, {"type": "t", "text": ", while its overexpression has also been linked to hepatocellular"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": ", bladder"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ", gastric"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": ", glioma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": ", neuroblastoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": ", and esophageal cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": " Moreover, aberrant SLC34A2 expression may contribute to the transformation of alveolar type II cells by facilitating malignant conversion toward adenocarcinoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic studies on SLC34A2 have further uncovered its involvement in key regulatory networks that modulate tumor progression and normal cellular physiology. Investigations into antibody–drug conjugates directed against NaPi–IIb highlight the translational potential of SLC34A2 as a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": " Detailed analyses of the hNaPi–IIb gene promoter have revealed critical cis–acting elements and transcription factor binding—underscoring the fine regulation of phosphate transport."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": " In addition, signaling studies have implicated the SPAK/OSR1 kinases in governing NaPi–IIb activity"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": ", while investigations into sodium–lithium countertransport have linked SLC34A2 variants to ion transport regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": " Complementary work on the impact of pathogenic variants further emphasizes how specific mutations modulate transporter expression and function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "38", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ayse Corut, Abdurrahman Senyigit, Sibel Aylin Ugur, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/508263"}], "href": "https://doi.org/10.1086/508263"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16960801"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16960801"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": " Huqun, Shinyu Izumi, Hitoshi Miyazawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Crit Care Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1164/rccm.200609-1274OC"}], "href": "https://doi.org/10.1164/rccm.200609-1274OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17095743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17095743"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Teruo Tachibana, Koichi Hagiwara, Takeshi Johkoh "}, {"type": "b", "children": [{"type": "t", "text": "Pulmonary alveolar microlithiasis: review and management."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Opin Pulm Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MCP.0b013e32832d03bb"}], "href": "https://doi.org/10.1097/MCP.0b013e32832d03bb"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19617834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19617834"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xinzhen Yin, Huiying Wang, Dingwen Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Respir Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.rmed.2012.10.016"}], "href": "https://doi.org/10.1016/j.rmed.2012.10.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23164546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23164546"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Omer Tamer Dogan, Sefa Levent Ozsahin, Eylem Gul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A frame-shift mutation in the SLC34A2 gene in three patients with pulmonary alveolar microlithiasis in an inbred family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Intern Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2169/internalmedicine.49.2702"}], "href": "https://doi.org/10.2169/internalmedicine.49.2702"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20046000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20046000"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Åsa Lina M Jönsson, Elisabeth Bendstrup, Susie Mogensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eight novel variants in the "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC34A2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " gene in pulmonary alveolar microlithiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Respir J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1183/13993003.00806-2019"}], "href": "https://doi.org/10.1183/13993003.00806-2019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31831582"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31831582"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yang Yang, Jun-Hua Qiao, Ji-Hong An, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Detection of SLC34A2 in patients with pulmonary alveolar microlithiasis and the effect of SLC34A2 on transportation of calcium and phosphate in human alveolar epithelial cells]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Jie He He Hu Xi Za Zhi (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19134407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19134407"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "You-qing Zhong, Cheng-ping Hu, Xing-dong Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[A novel mutation of the SLC34A2 gene in a Chinese pedigree with pulmonary alveolar microlithiasis]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2009)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20017296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20017296"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Åsa Lina M Jönsson, Ole Hilberg, Ulf Simonsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Orphanet J Rare Dis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13023-023-02712-7"}], "href": "https://doi.org/10.1186/s13023-023-02712-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37259144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37259144"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xuechao Zhang, Xixian Ke, Qiang Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7538"}], "href": "https://doi.org/10.18632/oncotarget.7538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26910912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26910912"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yu Wang, Weihan Yang, Qiang Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomed Sci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12929-015-0158-7"}], "href": "https://doi.org/10.1186/s12929-015-0158-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26156586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26156586"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zhanxin Jiang, Yanhong Hao, Xiaoquan Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-4928-y"}], "href": "https://doi.org/10.1007/s13277-016-4928-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26846105"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26846105"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhaoxuan Zhang, Shan Ye, Min Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317720212"}], "href": "https://doi.org/10.1177/1010428317720212"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28720066"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28720066"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Guanqun Ge, Can Zhou, Yu Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4226-0"}], "href": "https://doi.org/10.1007/s13277-015-4226-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26546432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26546432"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Dar-Ren Chen, Su-Yu Chien, Shou-Jen Kuo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Res (2010)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21036732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21036732"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yonggang Lv, Ting Wang, Jing Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " breast cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317695927"}], "href": "https://doi.org/10.1177/1010428317695927"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28381172"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28381172"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xiaozhou Liu, Xing Zhou, Haidong Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2017.3750"}], "href": "https://doi.org/10.1089/dna.2017.3750"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28777670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28777670"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jing He, Mingxia Zhou, Xiaoyan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-020-1181-z"}], "href": "https://doi.org/10.1038/s41388-020-1181-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32005974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32005974"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Monika Gałeza-Kulik, Jadwiga Zebracka, Sylwia Szpak-Ulczok, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Expression of selected genes involved in transport of ions in papillary thyroid carcinoma]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endokrynol Pol (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17091453"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17091453"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Kristina Levan, Matin Mehryar, Constantina Mateoiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3289-2"}], "href": "https://doi.org/10.1186/s12885-017-3289-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28464843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28464843"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mariana Lopes dos Santos, Fernanda Perez Yeda, Lilian Rumi Tsuruta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0070332"}], "href": "https://doi.org/10.1371/journal.pone.0070332"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23936189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23936189"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "M Shyian, V Gryshkova, O Kostianets, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative analysis of SLC34A2 expression in different types of ovarian tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Oncol (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21716206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21716206"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ibere Cauduro Soares, Kleber Simões, Jorge Estefano Santana de Souza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In silico analysis and immunohistochemical characterization of NaPi2b protein expression in ovarian carcinoma with monoclonal antibody Mx35."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/pai.0b013e318228e232"}], "href": "https://doi.org/10.1097/pai.0b013e318228e232"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22553815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22553815"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xu Li, Junjie Xing, Hantao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20180268"}], "href": "https://doi.org/10.1042/BSR20180268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30038060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30038060"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Liguo Liu, Yi Yang, Xueming Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.01.124"}], "href": "https://doi.org/10.1016/j.biopha.2018.01.124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29653487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29653487"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Ramilia Vlasenkova, Alsina Nurgalieva, Natalia Akberova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC34A2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " as a Potential Prognostic Marker of Oncological Diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom11121878"}], "href": "https://doi.org/10.3390/biom11121878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34944522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34944522"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yanhua Li, Xia Chen, Hong Lu "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504016X14719078133483"}], "href": "https://doi.org/10.3727/096504016X14719078133483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28281971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28281971"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Wen Ye, Cui Chen, Ying Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.13"}], "href": "https://doi.org/10.1038/cddis.2017.13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28151475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28151475"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Lanfang Zhang, Xiaohe Guo, Lili Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22768"}], "href": "https://doi.org/10.1002/mc.22768"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29178392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29178392"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zhijun Bao, Lihua Chen, Shiwen Guo "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28305"}], "href": "https://doi.org/10.1002/jcb.28305"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30592329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30592329"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jianlong Chen, Pengcheng Wang, Renduan Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3β-mediated activation of Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Open Bio (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/2211-5463.12594"}], "href": "https://doi.org/10.1002/2211-5463.12594"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30868061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30868061"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yi Xu, Shiyu Duan, Wen Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.15314"}], "href": "https://doi.org/10.1111/1759-7714.15314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38720472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38720472"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Weihan Yang, Yu Wang, Qiang Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2014.2376"}], "href": "https://doi.org/10.3892/mmr.2014.2376"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25017204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25017204"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "David E Gerber, Jeffrey R Infante, Michael S Gordon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-18-3965"}], "href": "https://doi.org/10.1158/1078-0432.CCR-18-3965"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31540980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31540980"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Hua Xu, Jennifer K Uno, Michael Inouye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00396.2004"}], "href": "https://doi.org/10.1152/ajpgi.00396.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15458926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15458926"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Myriam Fezai, Bernat Elvira, Jamshed Warsi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-Regulation of Intestinal Phosphate Transporter NaPi-IIb (SLC34A2) by the Kinases SPAK and OSR1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Blood Press Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000368531"}], "href": "https://doi.org/10.1159/000368531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26506223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26506223"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Xiaojing Zheng, Candace M Kammerer, Laura A Cox, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hypertens (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ajh.2008.355"}], "href": "https://doi.org/10.1038/ajh.2008.355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19119262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19119262"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Ramziya Kiyamova, Vitalina Gryshkova, Galina Ovcharenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development of monoclonal antibodies specific for the human sodium-dependent phosphate co-transporter NaPi2b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hybridoma (Larchmt) (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/hyb.2008.0015"}], "href": "https://doi.org/10.1089/hyb.2008.0015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18724815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18724815"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Shang Dandan, Chen Yuqin, Lu Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel deletion of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC34A2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in Chinese patients of PAM shares mutation hot spot with fusion gene "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SLC34A2-ROS1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Genet (2018)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30262706"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30262706"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Åsa Lina M Jönsson, Nati Hernando, Thomas Knöpfel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genomics (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40246-022-00387-y"}], "href": "https://doi.org/10.1186/s40246-022-00387-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35443721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35443721"}]}]}]}
|
| Synonyms | NAPI-IIB, NAPI-3B, NPTIIB |
| Proteins | NPT2B_HUMAN |
| NCBI Gene ID | 10568 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC34A2 has 6,115 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 118 datasets.
Click the + buttons to view associations for SLC34A2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SLC34A2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC34A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC34A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC34A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC34A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC34A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC34A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SLC34A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC34A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC34A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SLC34A2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC34A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC34A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC34A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SLC34A2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SLC34A2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SLC34A2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing SLC34A2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC34A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC34A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC34A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC34A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC34A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC34A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC34A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC34A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC34A2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC34A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for SLC34A2 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SLC34A2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC34A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC34A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC34A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC34A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC34A2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC34A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC34A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC34A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC34A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SLC34A2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC34A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC34A2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC34A2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC34A2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC34A2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SLC34A2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SLC34A2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC34A2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC34A2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC34A2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC34A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC34A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC34A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SLC34A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SLC34A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC34A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SLC34A2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC34A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC34A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC34A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SLC34A2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SLC34A2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC34A2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC34A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SLC34A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC34A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SLC34A2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC34A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC34A2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC34A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SLC34A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SLC34A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC34A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SLC34A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC34A2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC34A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SLC34A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC34A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SLC34A2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SLC34A2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SLC34A2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SLC34A2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SLC34A2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC34A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SLC34A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC34A2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC34A2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SLC34A2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC34A2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SLC34A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC34A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SLC34A2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC34A2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC34A2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SLC34A2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SLC34A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SLC34A2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SLC34A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC34A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC34A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC34A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC34A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC34A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC34A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC34A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC34A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC34A2 protein from the WikiPathways Pathways 2024 dataset. | |